Healthcare 5.0: A Study on Improving Personalized Care

摘要

Medicine has been chiefly a reactionary profession throughout history. Even today, one has to wait until diseases have manifested before attempting to treat or cure them. And because the genetic and environmental components that contribute to major diseases like Cancer, Alzheimer’s and cardiovascular diseases are not fully understandable, our efforts to treat them are often haphazard, unpredictable, and inefficient. As a result, the drugs and therapies developed are evaluated on large groups of people and given based on statical averages. And because of the genetic variances, they function for some patients but not for others. Every prescription medicine now on the market only works for half of the people who take it. Based on each patient’s unique genetic composition and environment circumstances, personalized medicine is a critical milestone to be attained to address this issue. Artificial intelligence and blockchain have recently been innovations in the healthcare industry. Furthermore, blockchain can control patient data privacy among participants. It uses asymmetric cryptography to secure transactions between users without the need for any intermediary or a trusted third party, thanks to smart contracts. On the other hand, Artificial intelligence provides intellect and decision-making capabilities for robots similar to humans. This study also identifies and analyses open research problems associated with blockchain and artificial intelligence in personalized medicine.